Medifast Inc reports results for the quarter ended December 31 - Earnings Summary

Medifast

18/02/2025 22:01

* Medifast Inc  MED.N  reported quarterly adjusted earnings
of 10
cents​​ per share for the quarter ended December 31, lower than
the same quarter last year, when the company reported EPS of 55
cents.  The mean expectation of two analysts for the quarter was
for a loss of 16 cents per share. Wall Street expected
results to range from -22 cents to -10 cents per share.
    * Revenue fell 37.7% to $119.00 million from a year ago;
analysts
expected $114.25 million. 
    * Medifast Inc's reported EPS for the quarter was 7 cents​.
    * The company reported quarterly net income of $800
thousand.
    * Medifast Inc shares had fallen by 8.0% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the food
processing
peer group is also "hold"

Wall Street's median 12-month price target for Medifast Inc is
$16.50 
This summary was machine generated from LSEG data February 18 at
10:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -0.16          0.10           Beat
 Sep. 30 2024      -0.28          0.35           Beat
 Jun. 30 2024      0.39           0.92           Beat
 Mar. 31 2024      0.78           0.66           Missed